SGR-2921

N/A

Report date: 2025/09/23 20:00:05
NME

Base Information

Drug NameSGR-2921
Drug Alias NameSGR-2921
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell division cycle 7-related protein kinase inhibitors
TargetsCell division cycle 7-related protein kinase
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesHematologic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSchrodinger Inc
China Registration ClassN/A

Develop Information

Active CompaniesSchrodinger Inc
Inactive CompaniesSchrödinger Inc
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A